Metagenomi is a Biotech company. It has raised $300M in total funding. Latest round: Series B.
Metagenomi is a Biotech company. Metagenomi has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Metagenomi runs through 2022; nothing later has been disclosed. Investors on record include PFM Health Sciences, Farallon Capital Management, Moderna, Leaps by Bayer, Bristol Myers Squibb, Novo Holdings A/S and 10 others. 16 distinct backers are named across the disclosed rounds.
We update the Metagenomi record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026